AGP Executive Report
Last update: 8 hours agoHeat & El Niño Preparedness (Caribbean): A climate psychologist warns that rising temperatures during El Niño can quietly harm sleep, mood, hydration, learning and safety—urging St. Vincent and the wider Caribbean to treat heat stress as a public health risk, not just discomfort. Pharma Performance (LATAM): Knight Therapeutics reported Q2 results with revenue up 34% year over year to $144.2M, driven by promoted products and LATAM currency strength. Mental Health Policy (Puerto Rico): Gov. Jenniffer González-Colón signed an executive order to assess a pilot clinical research program for emerging therapies, including investigational ibogaine, aiming to expand regulated trial pathways for severe mental health and substance-use disorders. GLP-1 Demand (Regional impact): Eli Lilly said Mounjaro and Zepbound sales surged, with international growth including Latin America, underscoring how GLP-1s are reshaping regional diabetes and obesity markets. Cardiac Tech Market Signals: New market outlooks highlight continued growth in ECG and related monitoring tools, reflecting demand for earlier detection and remote care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
